VANCOUVER, British Columbia — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), a biotechnology company commercializing AI-driven voice analytics for intoxication and fatigue detection, has announced the completion of manufacturing and delivery of its first prototype Edge AI Intoxication Detection Kiosks. These prototypes represent a hardware and software solution designed for office and industrial use to detect intoxication and fatigue, thereby improving workplace safety.
Edge AI Kiosks for Workplace Safety
The technology leverages voice analysis powered by artificial intelligence to identify signs of intoxication and fatigue. The kiosks will now undergo rigorous testing, model validation, and data analysis in collaboration with industry experts, speech specialists, and software engineers. MindBio is targeting industries where regulatory mandates require drug and alcohol testing, such as mining, aviation, construction, heavy transport, and law enforcement. These sectors face challenges with high-volume testing, which is often time-consuming, physically invasive, and expensive.
CEO Statement
Justin Hanka, CEO of MindBio, stated: “The delivery of MindBio’s first prototype model Edge AI intoxication and fatigue detection kiosks is a positive advancement for the Company in delivering useful solutions to detect intoxication and fatigue from voice.”
About MindBio Therapeutics Corp.
MindBio is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. Its AI prediction model utilizes over 50 million data points to predict alcohol intoxication with remarkable accuracy using only the human voice. The company is developing an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for detecting drug and alcohol intoxication in environments such as mining, aviation, construction, and law enforcement.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws, including the company’s ability to complete offerings and option grants as announced, and the development of its enterprise platform using voice and AI for detecting drug and alcohol intoxication. Forward-looking statements can be identified by words such as “anticipate,” “intend,” “plan,” “budget,” “believe,” “project,” “estimate,” “expect,” “scheduled,” “forecast,” “strategy,” “future,” “likely,” “may,” “to be,” “could,” “would,” “should,” “will,” and similar references to future periods or negative terminology. These statements are based on assumptions as of the date provided, but there is no assurance that such assumptions will reflect actual outcomes.
For further information, contact: Justin Hanka, Chief Executive Officer, +61 433140886, justin@mindbiotherapeutics.com, www.mindbiotherapeutics.com.
